BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1577893)

  • 1. Cognitive dysfunction in an HIV-infected patient.
    Singer EJ
    Hosp Pract (Off Ed); 1992 May; 27(5):91-9, discussion 99-100. PubMed ID: 1577893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebral changes and HIV infection. Diagnostic methods are continuously improved].
    Alexius B
    Lakartidningen; 1993 Nov; 90(46):4092-3. PubMed ID: 7903112
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological deficit in haemophiliacs with human immunodeficiency virus.
    Turnbull O; Saling MM; Kaplan-Solms K; Cohn R; Schoub B
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):175-7. PubMed ID: 2019847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale.
    Smith CA; van Gorp WG; Ryan ER; Ferrando SJ; Rabkin J
    J Acquir Immune Defic Syndr; 2003 May; 33(1):116-8. PubMed ID: 12792365
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-associated neurocognitive disorders: still a hot topic?
    Levy I
    Isr Med Assoc J; 2015 Jan; 17(1):52-3. PubMed ID: 25739179
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuropsychological changes in drug addicts infected with human immunodeficiency virus].
    Sopelana P; Débora M; López-Calvo S; García-Alvarez JC; Polo C
    Arch Neurobiol (Madr); 1992; 55(5):228-34. PubMed ID: 1482276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.
    Cattie JE; Doyle K; Weber E; Grant I; Woods SP;
    J Clin Exp Neuropsychol; 2012; 34(9):906-18. PubMed ID: 22731608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV infection associated cognitive disorders].
    Manea M; Ruşanu V; Patrichi BE; Stoean R; Pădurariu A; Puiu GM
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):598-601. PubMed ID: 20201238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function in HIV-1-infected drug users.
    Shor-Posner G
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S70-3. PubMed ID: 11126430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive neuropsychology of HIV-associated neurocognitive disorders.
    Woods SP; Moore DJ; Weber E; Grant I
    Neuropsychol Rev; 2009 Jun; 19(2):152-68. PubMed ID: 19462243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT with 99mTc-HMPAO in subjects with HIV infection: cognitive dysfunction correlates with high uptake.
    Christensson B; Ljungberg B; Ryding E; Svenson G; Rosén I
    Scand J Infect Dis; 1999; 31(4):349-54. PubMed ID: 10528871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological evaluation of the HIV patient.
    Stern Y
    Psychiatr Clin North Am; 1994 Mar; 17(1):125-34. PubMed ID: 8190661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cognitive function in asymptomatic HIV-positive subjects.
    Grassi MP; Perin C; Borella M; Mangoni A
    Eur Neurol; 1999; 42(4):225-9. PubMed ID: 10567820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.
    Janssen MA; Bosch M; Koopmans PP; Kessels RP
    J Neurovirol; 2015 Aug; 21(4):383-90. PubMed ID: 25678141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobehavioral correlates of perceived mental and motor slowness in HIV infection and AIDS.
    Lopez OL; Wess J; Sanchez J; Dew MA; Becker JT
    J Neuropsychiatry Clin Neurosci; 1998; 10(3):343-50. PubMed ID: 9706543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.